Yanling Zhao

2.6k total citations · 3 hit papers
76 papers, 1.9k citations indexed

About

Yanling Zhao is a scholar working on Molecular Biology, Epidemiology and Pharmacology. According to data from OpenAlex, Yanling Zhao has authored 76 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 21 papers in Epidemiology and 20 papers in Pharmacology. Recurrent topics in Yanling Zhao's work include Pharmacological Effects of Natural Compounds (17 papers), Liver Disease Diagnosis and Treatment (11 papers) and Hepatitis B Virus Studies (7 papers). Yanling Zhao is often cited by papers focused on Pharmacological Effects of Natural Compounds (17 papers), Liver Disease Diagnosis and Treatment (11 papers) and Hepatitis B Virus Studies (7 papers). Yanling Zhao collaborates with scholars based in China, United States and France. Yanling Zhao's co-authors include Xiao Ma, Shizhang Wei, Xiaohe Xiao, Qichao Hu, Weijun Kong, Manyi Jing, Xing Li, Haotian Li, Cheng Jin and Wenwen Zhang and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Yanling Zhao

70 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Network pharmacology prediction and molecular docking-based strategy to explore the potential mechanism of Huanglian Jiedu Decoction against sepsis

2022 262 citations Xing Li, Shizhang Wei et al. Computers in Biology and Medicine profile →
Baicalin and the liver-gut system: Pharmacological bases explaining its therapeutic effects

2021 171 citations Qichao Hu, Wenwen Zhang et al. profile →
Diabetic nephropathy: Focusing on pathological signals, clinical treatment, and dietary regulation

2023 99 citations Qichao Hu, Xiao Ma et al. Biomedicine & Pharmacotherapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yanling Zhao China	22	848	441	322	292	274	76	1.9k
Sheng‐Teng Huang Taiwan	28	937 1.1×	394 0.9×	261 0.8×	282 1.0×	466 1.7×	93	2.2k
Xia Gong China	29	667 0.8×	456 1.0×	215 0.7×	254 0.9×	299 1.1×	44	1.8k
Jinjun Shan China	27	1.2k 1.4×	434 1.0×	298 0.9×	258 0.9×	289 1.1×	151	2.3k
Robert Domitrović Croatia	28	748 0.9×	686 1.6×	370 1.1×	346 1.2×	221 0.8×	54	2.5k
Chian‐Jiun Liou Taiwan	33	1.1k 1.2×	335 0.8×	306 1.0×	367 1.3×	246 0.9×	74	2.4k
Tom Huang Australia	23	1.2k 1.4×	288 0.7×	369 1.1×	232 0.8×	245 0.9×	43	2.4k
Jeng‐Shyan Deng Taiwan	26	840 1.0×	394 0.9×	291 0.9×	141 0.5×	204 0.7×	49	1.8k
Mohammed A. Alsahli Saudi Arabia	27	676 0.8×	242 0.5×	283 0.9×	162 0.6×	250 0.9×	67	1.9k
Li‐Hua Lian China	31	1.0k 1.2×	540 1.2×	301 0.9×	679 2.3×	264 1.0×	96	2.4k
Chunhua Ma China	28	1.2k 1.4×	339 0.8×	209 0.6×	182 0.6×	268 1.0×	56	2.3k

Countries citing papers authored by Yanling Zhao

Since Specialization

Citations

This map shows the geographic impact of Yanling Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanling Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanling Zhao more than expected).

Fields of papers citing papers by Yanling Zhao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanling Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanling Zhao. The network helps show where Yanling Zhao may publish in the future.

Co-authorship network of co-authors of Yanling Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Yanling Zhao. A scholar is included among the top collaborators of Yanling Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanling Zhao. Yanling Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

An, Yongcheng, Hongbin Zhao, Changhao He, et al.. (2025). Xiasangju alleviates hepatic insulin resistance in db/db mice via AMPK pathway: Mechanisms and active components study. International Immunopharmacology. 156. 114675–114675.

Sun, Rong, Yi Zeng, Qichao Hu, et al.. (2025). Exploration of the Combined Mechanism of Direct and Indirect Effects of Paeoniflorin in the Treatment of Cholestasis. Inflammation. 48(5). 3006–3021.

He, Changhao, Yongcheng An, Yanling Zhao, et al.. (2025). Gut microbiota modified by Mulberry leaf water extract improves T2DM through browning of WAT/BAT activation mediated by SCFAs-AMPK/SIRT1/PGC-1α signaling pathway. Journal of Ethnopharmacology. 353(Pt B). 120408–120408. 1 indexed citations

Hu, Qichao, Tao Jiang, Pan Gao, et al.. (2024). Paeoniflorin alleviates DSS-induced ulcerative colitis by suppressing inflammation, oxidative stress, and apoptosis via regulating serum metabolites and inhibiting CDC42/JNK signaling pathway. International Immunopharmacology. 142(Pt A). 113039–113039. 6 indexed citations

Yang, Chan, Shuo Tian, Yanling Zhao, et al.. (2024). A unique fluorescence metal-organic framework for ultrasensitive fluorescent and colorimetric bimodal detection of phosphate. Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy. 329. 125571–125571. 4 indexed citations

Li, Xing, Shizhang Wei, Xiao Ma, et al.. (2022). Network pharmacology prediction and molecular docking-based strategy to explore the potential mechanism of Huanglian Jiedu Decoction against sepsis. Computers in Biology and Medicine. 144. 105389–105389. 262 indexed citations breakdown →

Chen, Lisheng, Ruilin Wang, Honghong Liu, et al.. (2021). Clinical Efficacy and Safety of Qishen Yiqi Dropping Pill Combined with Conventional Western Medicine in the Treatment of Chronic Heart Failure: A Systematic Review and Meta-Analysis. Evidence-based Complementary and Alternative Medicine. 2021. 1–13. 10 indexed citations

Hao, Junjie, Jing Liu, Xuan Wang, et al.. (2019). Integrated Metabolomics and Network Pharmacology Study on Immunoregulation Mechanisms ofPanax ginsengthrough Macrophages. Evidence-based Complementary and Alternative Medicine. 2019. 1–14. 9 indexed citations

Wang, Xu, Yuling Tian, Hongbo Jiang, et al.. (2019). Analysis on pathogeny and clinical of encephalitis and meningitis syndrome in children. Zhonghua shiyong erke linchuang zazhi. 34(12). 926–929.

10.

Gao, Sijia, Xuelin Zhou, Honghong Liu, et al.. (2019). Simultaneous Determination of Schisandrin and Promethazine with Its Metabolite in Rat Plasma by HPLC-MS/MS and Its Application to a Pharmacokinetic Study. International Journal of Analytical Chemistry. 2019. 1–13. 7 indexed citations

11.

Zhang, Lu, Xiaohua Lu, Jiabo Wang, et al.. (2017). Zingiberis rhizoma mediated enhancement of the pharmacological effect of aconiti lateralis radix praeparata against acute heart failure and the underlying biological mechanisms. Biomedicine & Pharmacotherapy. 96. 246–255. 31 indexed citations

12.

Zhou, Xuelin, Haotian Li, Sijia Gao, et al.. (2017). Inhibition activity of a traditional Chinese herbal formula Huang-Lian-Jie-Du-Tang and its major components found in its plasma profile on neuraminidase-1. Scientific Reports. 7(1). 15549–15549. 33 indexed citations

13.

Xy, Yang, Quan Zhou, Szu‐Yuan Wu, et al.. (2016). High expression of S100A8 gene is associated with drug resistance to etoposide and poor prognosis in acute myeloid leukemia through influencing the apoptosis pathway. SHILAP Revista de lepidopterología. 1 indexed citations

14.

Li, Pengyan, Jiabo Wang, Zhirui Yang, et al.. (2016). Inhibition of Sophocarpine on Poly I: C/D-GalN-Induced Immunological Liver Injury in Mice. Frontiers in Pharmacology. 7. 256–256. 11 indexed citations

15.

Han, Xue, Mingquan Wu, Zhirui Yang, et al.. (2016). Comprehensive Evaluation of Powdered Chinese Herbal Medicines-An Exemplification of Isatidis Radix. Chinese Herbal Medicines. 8(3). 286–292. 1 indexed citations

16.

Wang, Hao, Yang Yu, Zheng Jiang, et al.. (2016). Next-generation proteasome inhibitor MLN9708 sensitizes breast cancer cells to doxorubicin-induced apoptosis. Scientific Reports. 6(1). 26456–26456. 41 indexed citations

17.

Kong, Weijun, Zulun Li, Xiaohe Xiao, & Yanling Zhao. (2010). Quality control forCoptidis rhizomathrough the determination of five alkaloids by HPLC–ELSD coupled with chemometrics. Natural Product Research. 24(17). 1616–1629. 12 indexed citations

18.

Fan, Yihui, Renfang Mao, Yanling Zhao, et al.. (2009). Tumor Necrosis Factor-α Induces RelA Degradation via Ubiquitination at Lysine 195 to Prevent Excessive Nuclear Factor-κB Activation. Journal of Biological Chemistry. 284(43). 29290–29297. 14 indexed citations

19.

Huang, Meng, Yunguang Sun, Wan Seok Yang, et al.. (2007). [583] ACH-806: A POTENT INHIBITOR OF HCV REPLICATION WITH A NOVEL MECHANISM OF ACTION. Journal of Hepatology. 46. S221–S221. 8 indexed citations

20.

Yan, Dan, et al.. (2007). [Comparison of properties of Mahuang decoction and Maxing Shigan decoction based on biothermodynamics].. PubMed. 32(5). 421–4. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact